Lam Research Corporation vs Prospect Capital Corporation — how do they compare? Lam Research Corporation trades at $319 (market cap $401.19B), while Prospect Capital Corporation trades at $1.75 (market cap $974.22M). The key difference: Lam Research Corporation is far larger — about 411.8× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays the higher dividend (23.01%). Which is the better fit depends on your goals — on Pluang, investors hold Lam Research Corporation for 60 Days and Prospect Capital Corporation for 78 Days on average.
| LRCX | PSEC | |
|---|---|---|
Market Cap | $401.19B | $974.22M |
Volume | 8,960,892 | 5,779,996 |
Sector | Technology | Financials |
52-Week High | $433.33 | $3.05 |
52-Week Low | $131.37 | $1.82 |
Typical Hold Time | 60 Days | 78 Days |
Enterprise Value | $399.35B | $2.73B |
Dividend Yield | 0.41% | 23.01% |
Signals from Pluang's Aura AI — not financial advice
Lam Research (LRCX) is trading at $319.42, down 3.06% on the day, amid a broader bearish technical signal. The stock exhibits strong fundamentals with revenue of $18.44B in 2025 and a net income margin of 31.27%, supported by three consecutive quarterly earnings beats. Analyst consensus is overwhelmingly bullish with a 78% buy rating and a $375.68 price target, citing AI-driven demand for semiconductor equipment. Recent news highlights the company's strategic positioning in AI infrastructure and margin expansion targets.
The outlook for LRCX is positive, driven by robust earnings growth and expanding profitability, though valuation multiples remain elevated. Key risks include cyclical semiconductor demand and competitive pressures. With strong institutional support and a clear growth trajectory, the stock presents a compelling opportunity for long-term investors, contingent on sustained execution in a dynamic market.
PSEC trades at $1.80, down 2.17% today, with a bearish technical outlook showing 18 sell signals versus 5 buy signals. The company shows mixed fundamentals with a low P/B ratio of 0.33 but concerning profitability metrics including 1.01% ROE and negative revenue of -$407M for 2025. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $0.15 beating the $0.11 estimate. The stock pays a regular $0.04 monthly dividend, providing income appeal despite operational challenges.
PSEC presents a high-risk opportunity with significant challenges. The 62% NAV discount and consistent dividend payments offer value for income-focused investors, but persistent revenue volatility, negative cash flow, and bearish analyst sentiment (55% hold rating) suggest caution. Key risks include ongoing portfolio contraction and declining investment income, requiring careful monitoring of quarterly results and NAV stability for any turnaround signs.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →